INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 147 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2015. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $758,000 | +62.3% | 82,422 | +108.0% | 0.19% | +61.5% |
| Q3 2016 | $467,000 | -9.0% | 39,624 | 0.0% | 0.12% | -17.0% |
| Q2 2016 | $513,000 | -19.1% | 39,624 | -0.0% | 0.14% | -17.1% |
| Q1 2016 | $634,000 | -44.1% | 39,640 | 0.0% | 0.17% | -43.9% |
| Q4 2015 | $1,135,000 | +113400.0% | 39,640 | +99000.0% | 0.30% | – |
| Q3 2015 | $1,000 | -50.0% | 40 | -20.0% | 0.00% | – |
| Q2 2015 | $2,000 | 0.0% | 50 | +47.1% | 0.00% | – |
| Q1 2015 | $2,000 | 0.0% | 34 | -12.8% | 0.00% | – |
| Q4 2014 | $2,000 | -33.3% | 39 | -55.7% | 0.00% | – |
| Q3 2014 | $3,000 | -25.0% | 88 | -45.0% | 0.00% | – |
| Q2 2014 | $4,000 | -20.0% | 160 | +15.1% | 0.00% | -100.0% |
| Q1 2014 | $5,000 | -16.7% | 139 | -18.2% | 0.00% | 0.0% |
| Q4 2013 | $6,000 | +20.0% | 170 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $5,000 | – | 170 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 5,406,844 | $52,014,000 | 0.66% |
| ETF MANAGERS GROUP, LLC | 282,268 | $3,255,000 | 0.24% |
| Mirae Asset Global Investments Co., Ltd. | 1,470,996 | $14,151,000 | 0.19% |
| Financial Gravity Companies, Inc. | 4,467 | $42,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 67,200 | $646,000 | 0.04% |
| TCI Wealth Advisors, Inc. | 7,766 | $75,000 | 0.03% |
| Freedom Investment Management, Inc. | 64,741 | $623,000 | 0.03% |
| GAM Holding AG | 83,940 | $808,000 | 0.02% |
| SFMG, LLC | 11,994 | $115,000 | 0.02% |
| SHELL ASSET MANAGEMENT CO | 95,127 | $915,000 | 0.02% |